| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5733733 | Journal of Surgical Research | 2017 | 9 Pages |
Abstract
The utilization of chemotherapy has declined over time after resection for stage II colon cancer. Chemotherapy was not independently associated with improved OS or RFS in this study group, including in patients with high-risk features. Future prospective studies should strive to identify the subset of stage II colon cancer patients that will benefit the most from the addition of adjuvant chemotherapy.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Aslam MD, MPH, Leigh MD, Ajay V. MD,